
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+8
Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services that improve the productivity of oncology drug development. Using both in vitro to in vivo testing platforms companies can leverage the expertise at Champions Oncology to help guide decision making for clinical development scenarios. From screens using commercially-available and custom cell lines, to studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models, and modeling treatment response in the clinic, Champions Oncology is your partner in meeting todays needs and innovating for tomorrows challenges. At the core of our services is the Champions TumorGraft (CTG) platform,...
Translational oncology research,personalized oncology,patient derived xenograft,oncology pharmacology,immuno-oncology,flow cytometry,syngeneic models,humanized mouse models,gcp,clinical flow cytometry,pdx,3d organoid models,and clinical specialty testing
Champions oncology, inc operates in the Biotechnology industry.
Champions oncology, inc's revenue is 11m - 100m
Champions oncology, inc has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.